Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages

Article English OPEN
Mortaz, E; Adcock, IM; Ricciardolo, FLM; Varahram, M; Jamaati, H; Velayati, AA; Folkerts, G; Garssen, J; (2015)
  • Publisher: Public Library of Science
  • Journal: PLoS ONE,volume 10,issue 8 (issn: 1932-6203, eissn: 1932-6203)
  • Related identifiers: pmc: PMC4552661, doi: 10.1371/journal.pone.0136455
  • Subject: OBSTRUCTIVE PULMONARY-DISEASE | MD Multidisciplinary | Research Article | CHRONIC ASTHMA | RELEASE | INFLAMMATORY-BOWEL-DISEASE | ALVEOLAR MACROPHAGES | Medicine | Multidisciplinary Sciences | MURINE MODEL | EPITHELIAL-CELLS | COPD | Q | R | Science & Technology | Science | General Science & Technology | Science & Technology - Other Topics | NEUTROPHILS | PROBIOTICS
    mesheuropmc: food and beverages

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major global health problem with cigarette smoke (CS) as the main risk factor for its development. Airway inflammation in COPD involves the increased expression of inflammatory mediators such as CXCL-8 and IL... View more
  • References (59)
    59 references, page 1 of 6

    1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine. 2007; 176:532-555. PMID: 17507545

    2. Barnes PJ “Neutrophils find smoke attractive,” Science. 2010; 210:40-41.

    3. Adcock IM, Caramori G, and Barnes PJ Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011; 81: 265-268. doi: 10.1159/000324601 PMID: 21430413

    4. Rennard SI and Vestbo J COPD: the dangerous underestimate of 15%. The Lancet. 2006; 367:1216- 1219.

    5. Cosio MG, Saetta M, and Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. The New England Journal of Medicine. 2009; 360:2396-2454.

    6. Hogg JC, Chu F, Utokaparch S., Woods R, Elliott WM, Buzatu L, et al., “The nature of small airway obstruction in chronic obstructive pulmonary disease,” The New England Journal of Medicine. 2004; 350:2645-2653. PMID: 15215480

    7. Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agustí AG Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur Respir J. 2005; 25:647-52. PMID: 15802338

    8. Barnes PJ, Hansel TT. Prospects for new drugs for chronic obstructive pulmonary disease. Lancet. 2004; 364: 985-96. PMID: 15364192

    9. Tzanakis NE, Tsiligianni IG, and Siafakas NM. Pulmonary involvement and allergic disorders in inflammatory bowel disease. World Journal of Gastroenterology. 2010; 16:299-305. PMID: 20082474

    10. Black H, Mendoza M, and Murin S. “Thoracic manifestations of inflammatory bowel disease. Chest. 2007; 131:524-532. PMID: 17296657

  • Related Research Results (2)
  • Metrics
    No metrics available
Share - Bookmark